| USD millions | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | Trend | YoY |
|---|---|---|---|---|---|---|---|---|
| Revenue | 10.5 | 10.6 | 10.0 | 9.3 | 8.7 | 9.3 | +7.4% | |
| Cost of revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Gross profit | 10.5 | 10.6 | 10.0 | 9.3 | 8.7 | 9.3 | +7.4% | |
| Research & development | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Selling, general & administrative | 1.3 | 1.2 | 1.2 | 1.3 | 1.2 | 1.2 | −2.6% | |
| Selling & marketing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Operating expenses | 3.1 | 6.8 | 24.5 | 4.8 | 16.7 | 31.4 | +88.5% | |
| Operating income | 9.3 | 9.3 | 8.8 | 8.1 | 7.5 | 8.1 | +9.1% | |
| Interest expense | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Interest income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Other income / expense | (1.9) | (5.5) | 25.7 | 6.0 | (15.4) | (30.2) | −95.8% | |
| Pre-tax income | 7.4 | 3.8 | 34.5 | 14.1 | (8.0) | (22.1) | −176.8% | |
| Income tax | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Net income | 7.4 | 3.8 | 34.5 | 14.1 | (8.0) | (22.1) | −176.8% | |
| Discontinued operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Other net income adjustments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| EPS, basic (per share) | 0.65 | 0.33 | 3.03 | 1.23 | (0.70) | (1.94) | −177.1% | |
| EPS, diluted (per share) | 0.65 | 0.33 | 3.03 | 1.23 | (0.70) | (1.94) | −177.1% | |
| EBITDA | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Depreciation & amortization | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | +0.0 pts | |
| Operating margin | 88.1% | 88.2% | 87.9% | 86.3% | 85.8% | 87.1% | +1.3 pts | |
| Net margin | 70.5% | 35.9% | 343.9% | 151.0% | −91.8% | −236.6% | −144.8 pts |
Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.